Stock trading call: Buy Sun Pharma Advanced Research Company
Investors with a medium-term perspective can buy the stock of Sun Pharma Advanced Research Company (SPARC) at current levels. Last Friday, the stock12-01-2020
12-01-2020
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed intimation pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby furnish the details of loss of share certificates reported by shareholders of the Company, received from our Registrar and Transfer Agent, Link Intime India Private Limited, i.e. on January 8, 2020.08-01-2020
Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement
Intimation about NCLT Order on Scheme of Arrangement. For further details refer letter attached.27-12-2019
Sun Pharmaceutical Industries Ltd - 524715 - Closure of Trading Window
This is to inform you that in compliance with the Company''s Code of Conduct for prevention of Insider Trading, the window closure for trading by Designated Persons of the Company shall be with effect from Wednesday, 1st January, 2020 till 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter and nine months ended 31st December, 2019. The date of the Board Meeting of the Company for declaration of the financial results for quarter and nine months ended on 31st December, 2019 will be intimated in due course. This is for your information and record.26-12-2019
Issues at Sun Pharma's Halol plant may take 3-4 months to resolve, say analysts
Sun Pharma's issues with Halol was started in 2015, as the FDA issued a 'warning letter' subsequent to an inspection in September 201426-12-2019
US FDA woes may prolong recovery in Sun Pharma stock
Though it has received eight observations for its Halol unit, some analysts see most of the observations as procedural.According to analysts, the share of the Halol plant in total revenues is in high-single digits24-12-2019
Sun Pharmaceutical Industries Ltd - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 21, 2019 for Shanghvi Finance Pvt Ltd21-12-2019
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 21, 2019 for Shanghvi Finance Pvt Ltd21-12-2019
Sun Pharma skids as USFDA issues observations
Halol plant is one of the largest facilities contributing to US sales.16-12-2019
Sun Pharma's Halol facility gets 8 observations post USFDA inspection
The company is preparing the response to the observations, which will be submitted to the USFDA within 15 business days14-12-2019